[关于在慢性病患者中使用加多基对比剂]
François Cousin1, Martin Moïse1,2, Cédric Ilbert3
1Services de Médecine Nucléaire et Imagerie Oncologique, CHU de Liège, Belgique.
Revue medicale de Liege
|October 10, 2025
概括
基于加多的对比剂 (GBCA) 在慢性病 (CKD) 患者的磁共振成像 (MRI) 中更安全. 宏环GBCA提供了更好的稳定性和减少组织积累,最大限度地降低了与MRI对比剂相关的风险.
科学领域:
- 放射学和医学成像学 医学成像学
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
背景情况:
- 基于加多的对比剂 (GBCA) 对于磁共振成像 (MRI) 非常重要.
- 由于原体系统性纤维化风险,人们对慢性病 (CKD) 患者的GBCA安全性存在担忧.
- 由于不稳定性和组织保留风险,欧洲药品管理局 (EMA) 在2017年禁止了线性GBCA.
研究的目的:
- 在慢性病 (CKD) 患者中评估现代基对比剂 (GBCA) 的安全性.
- 评估加多 (Gd3+) 积累的风险和CKD患者的相关临床后果.
- 突出宏环GBCA在MRI程序中的优势,而不是线性GBCA.
主要方法:
- 最近关于加多 (Gd3+) 积累在正常和功能受损的患者中的研究的综述.
- 对线性与宏环性GBCA的化学稳定性和组织保留性能的分析.
- 评估GBCA在慢性病患者中使用的益处风险比率.
主要成果:
- 与线性GBCA相比,宏环GBCA表现出优越的稳定性和显著降低的加多 (Gd3+) 分离和组织积累.
- 在重复使用线性GBCA后观察到基底中加多 (Gd3+) 积累,即使在具有正常功能的患者中,也没有证明临床后果.
- 质性系统性纤维化风险在现代宏环性GBCA的使用下大大降低,即使在CKD患者中也是如此.
结论:
- 使用宏环加基对比剂 (GBCA) 的MRI在经过仔细的益处风险评估和剂量限制后,被认为对慢性病 (CKD) 患者是安全的.
- 宏环GBCA的增强稳定性将加多 (Gd3+) 解离和随后的组织积累的风险降至最低.
- 在GBCA技术的进步显著改善了安全性,使MRI成为CKD患者的可行选择.
相关概念视频
Acute Kidney Injury IV: Diagnostic Studies and Prevention
260
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
260
Chronic Kidney Disease III: Interprofessional Care
339
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
339
Radiological Investigation I: X-ray and CT
1.1K
Radiological investigations, including X-rays and computed tomography (CT) scans, are critical for diagnosing and evaluating various medical conditions. These imaging techniques provide valuable insights into the body's internal structures, aiding in the detection of abnormalities, assessment of disease progression, and development of treatment strategies. This article delves into two primary radiological investigations, chest X-rays and CT scans, outlining their purpose, procedures, and...
1.1K
Imaging Studies III: Computed Tomography
283
DefinitionComputed Tomography (CT) of the genitourinary (GU) tract is a non-invasive imaging modality that utilizes X-rays and computer processing to generate detailed cross-sectional images of the urinary system, encompassing the kidneys, ureters, bladder, and adjacent structures such as the adrenal glands.PurposeCT scans of the GU tract serve several diagnostic and therapeutic purposes, including:Diagnosis of Urinary Tract Diseases: Detects kidney stones, tumors, cysts, and congenital...
283
Imaging Studies VII: Vascular Imaging
311
DefinitionRenal angiography, also known as renal arteriography, is an imaging technique used to obtain a comprehensive view of blood flow and the vascular structure of blood vessels in the kidneys and surrounding areas.PurposeRenal angiography detects blood vessel abnormalities in the kidneys, such as aneurysms, stenosis, thrombosis, vascular tumors, and renal artery stenosis. It evaluates kidney function and guides interventional treatments like angioplasty or stent placement.Pre-Procedure...
311
Chronic Kidney Disease II: Clinical Manifestations
552
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
552


